Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Neurol Neurosurg Psychiatry ; 80(7): 767-72, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19240050

ABSTRACT

OBJECTIVE: To examine the relation between low contrast letter acuity, a new visual function test for multiple sclerosis (MS) trials, and vision targeted health related quality of life (HRQOL). METHODS: Patients in this cross sectional study were part of an ongoing investigation of visual function in MS. Patients were tested binocularly using low contrast letter acuity and Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity (VA) charts. The 25 Item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25), 10 Item Neuro-Ophthalmic Supplement to the NEI-VFQ-25, Impact of Visual Impairment Scale and Short Form 36 Health Survey (SF-36) were administered. RESULTS: Among 167 patients, mean age was 48 (10) years, with median Expanded Disability Status Scale (EDSS) 2.0 (range 1.0-7.5), and median binocular Snellen acuity equivalent (ETDRS charts) 20/16 (range 20/12.5 to 20/100). Reductions in vision specific HRQOL were associated with lower (worse) scores for low contrast letter acuity and VA (p<0.001, linear regression, accounting for age). Two line differences in visual function were associated, on average, with >4 point (6.7-10.9 point) worsening in the NEI-VFQ-25 composite score, reductions that are considered clinically meaningful. Scores for the 10 Item Neuro-Ophthalmic Supplement to the NEI-VFQ-25 also correlated well with visual function. Associations between reduced low contrast acuity and worse vision targeted HRQOL remained significant in models accounting for high contrast VA, EDSS and history of acute optic neuritis. CONCLUSIONS: Low contrast letter acuity scores correlate well with HRQOL in MS. Two line differences in scores for low contrast acuity and VA reflect clinically meaningful differences in vision targeted HRQOL. Low contrast acuity testing provides information on patient reported aspects of vision, supporting use of these measures in MS clinical trials.


Subject(s)
Contrast Sensitivity , Multiple Sclerosis/physiopathology , Quality of Life , Vision, Binocular , Adult , Female , Health Surveys , Humans , Linear Models , Male , Middle Aged , Quality of Life/psychology , Surveys and Questionnaires
2.
Neurology ; 69(23): 2128-35, 2007 Dec 04.
Article in English | MEDLINE | ID: mdl-17881718

ABSTRACT

OBJECTIVE: To examine the relation between low-contrast letter acuity, an emerging visual outcome for multiple sclerosis (MS) clinical trials, and brain MRI abnormalities in an MS cohort. METHODS: T2 lesion volume and brain parenchymal fraction were determined for whole brain and within visual pathway regions of interest. Magnetization transfer ratio histograms were examined. Vision testing was performed binocularly using low-contrast letter acuity (2.5%, 1.25% contrast) and high-contrast visual acuity (VA). Linear regression, accounting for age and disease duration, was used to assess the relation between vision and MRI measures. RESULTS: Patients (n = 45) were aged 44 +/- 11 years, with disease duration of 5 years (range <1 to 21), Expanded Disability Status Scale score of 2.0 (0 to 6.0), and binocular Snellen acuity of 20/16 (20/12.5 to 20/25). The average T2 lesion volume was 18.5 mm(3). Patients with lower (worse) low-contrast letter acuity and high-contrast VA scores had greater T2 lesion volumes in whole brain (2.5% contrast: p = 0.004; 1.25%: p = 0.002; VA: p = 0.04), Area 17 white matter (2.5%: p < 0.001; 1.25%: p = 0.02; VA: p = 0.01), and optic radiations (2.5%: p = 0.001; 1.25%: p = 0.02; VA: p = 0.007). Within whole brain, a 3-mm(3) increase in lesion volume corresponded, on average, to a 1-line worsening of low-contrast acuity, whereas 1-line worsening of high-contrast acuity corresponded to a 5.5-mm(3) increase. CONCLUSIONS: Low-contrast letter acuity scores correlate well with brain MRI lesion burden in multiple sclerosis (MS), supporting validity for this vision test as a candidate for clinical trials. Disease in the postgeniculate white matter is a likely contributor to visual dysfunction in MS that may be independent of acute optic neuritis history.


Subject(s)
Brain Diseases/complications , Brain Diseases/diagnosis , Brain/pathology , Multiple Sclerosis/complications , Vision Disorders/etiology , Visual Pathways/pathology , Adult , Brain Diseases/physiopathology , Cross-Sectional Studies , Female , Humans , Linear Models , Magnetic Resonance Imaging , Male , Prospective Studies , Visual Acuity
3.
AJNR Am J Neuroradiol ; 28(1): 3-8, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17213413

ABSTRACT

Combining an understanding of neuro-ophthalmologic anatomy with proper imaging techniques provides a powerful method to detect lesions involving the afferent and efferent visual pathways. Precise documentation of the extent of injury within the nervous system is becoming increasingly important to assess and monitor the effect of neurologic therapies. This review will focus on those common neuro-ophthalmologic problems that have exquisite localizing value on neuro-imaging.


Subject(s)
Image Enhancement , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Nystagmus, Pathologic/etiology , Ocular Motility Disorders/etiology , Optic Nerve Diseases/etiology , Pupil Disorders/etiology , Vision Disorders/etiology , Brain/pathology , Diagnosis, Differential , Humans , Nystagmus, Pathologic/pathology , Ocular Motility Disorders/diagnosis , Optic Nerve Diseases/diagnosis , Pupil Disorders/diagnosis , Vision Disorders/diagnosis , Visual Pathways/pathology
5.
Neurology ; 61(10): 1367-73, 2003 Nov 25.
Article in English | MEDLINE | ID: mdl-14638957

ABSTRACT

BACKGROUND: Visual dysfunction is one of the most common causes of disability in multiple sclerosis (MS). The Multiple Sclerosis Functional Composite (MSFC), a new clinical trial outcome measure, does not currently include a test of visual function. OBJECTIVE: To examine contrast letter acuity as a candidate visual function test for the MSFC. METHODS: Binocular contrast letter acuity testing (Sloan charts) was performed in a subgroup of participants from the International Multiple Sclerosis Secondary Progressive Avonex Controlled Trial (IMPACT Substudy) and in MS patients and disease-free control subjects from a cross-sectional study of visual outcome measures (Multiple Sclerosis Vision Prospective cohort [MVP cohort]). High-contrast visual acuity was measured in both studies; MVP cohort participants underwent additional binocular testing for contrast sensitivity (Pelli-Robson chart), color vision (D-15 desaturated test), and visual field (Esterman test, Humphrey Field Analyzer II). RESULTS: Contrast letter acuity (Sloan charts, p < 0.0001, receiver operating characteristic curve analysis) and contrast sensitivity (Pelli-Robson chart, p = 0.003) best distinguished MS patients from disease-free control subjects in the MVP cohort. Correlations of Sloan chart scores with MSFC and Expanded Disability Statue Scale (EDSS) scores in both studies were significant and moderate in magnitude, demonstrating that Sloan chart scores reflect visual and neurologic dysfunction not entirely captured by the EDSS or MSFC. CONCLUSIONS: Among clinical measures, contrast letter acuity (Sloan charts) and contrast sensitivity (Pelli-Robson chart) demonstrate the greatest capacity to identify binocular visual dysfunction in MS. Sloan chart testing also captures unique aspects of neurologic dysfunction not captured by current EDSS or MSFC components, making it a strong candidate visual function test for the MSFC.


Subject(s)
Multiple Sclerosis/diagnosis , Vision Tests , Adult , Contrast Sensitivity , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Visual Acuity
6.
J Neuroophthalmol ; 21(2): 99-102, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11450911

ABSTRACT

We report two patients who developed isolated visual symptoms and signs as initial manifestations of Creutzfeldt-Jakob disease (CJD). Both patients had normal conventional T1- and T2-weighted brain magnetic resonance (MR) images; in one patient, early cortical abnormalities were detected by diffusion-weighted and fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI). Results from the cerebrospinal fluid assay for the 14-3-3 brain protein were also negative in one patient, despite pathologic confirmation of CJD at autopsy. The Heidenhain variant of CJD should be considered in all patients who present with isolated visual manifestations, including homonymous hemianopsia and normal conventional brain MRI. Diffusion-weighted and FLAIR MRI may demonstrate early cortical abnormalities in patients with CJD. The CSF assay for the 14-3-3 protein may be normal, even in pathologically confirmed cases.


Subject(s)
Brain/pathology , Creutzfeldt-Jakob Syndrome/diagnosis , Hemianopsia/diagnosis , 14-3-3 Proteins , Aged , Creutzfeldt-Jakob Syndrome/cerebrospinal fluid , Fatal Outcome , Female , Hemianopsia/cerebrospinal fluid , Humans , Magnetic Resonance Imaging , Male , Tomography, Emission-Computed , Tyrosine 3-Monooxygenase/cerebrospinal fluid
7.
Pediatr Surg Int ; 15(7): 515-6, 1999.
Article in English | MEDLINE | ID: mdl-10525914

ABSTRACT

Masses in the inguinal canal other than hernias are rare occurrences, and their preoperative diagnosis requires a high index of suspicion. A soft, partly reducible groin mass in a 3-month-old boy proved to be a cystic lymphangioma within the inguinal canal. A 15-month-old female who presented with an irreducible inguinal mass was found to have a neuroblastoma metastasis in the groin. An irreducible groin mass in a 6-year-old female proved to be an inguinal canal epidermal inclusion cyst. A 14-year-old female presented with a painful groin swelling that represented an incarcerated hemorrhagic ovarian cyst. An awareness of the wide spectrum of entities other than the standard bowel, testicle, and ovary in the inguinal canal can help to identify uncommon pathologies preoperatively.


Subject(s)
Inguinal Canal , Soft Tissue Neoplasms/diagnosis , Adolescent , Child , Cysts/diagnosis , Female , Humans , Infant , Lymphangioma, Cystic/diagnosis , Male , Neuroblastoma/diagnosis , Ovarian Cysts/diagnosis
8.
J Nucl Med ; 24(11): 1039-45, 1983 Nov.
Article in English | MEDLINE | ID: mdl-6631524

ABSTRACT

The formulation of an "optimal" filter for improving the quality of digitally recorded nuclear medicine images is reported in this paper. The method forms a Metz filter for each image based upon the total number of counts in the image, which in turn determines the average noise level. The parameters of the filter were optimized for a set of simulated images using the minimization of the mean-square error as the criterion. The speed of the image formation results from the use of an array processor. In a study of localization receiver operating characteristics (LROC) using the Alderson liver phantom, a significant improvement in tumor localization was found in images filtered with this technique, compared with the original digital images and those filtered by the nine-point binomial smoothing algorithm. The technique has been found useful for the filtering of static and dynamic studies as well as the two-dimensional pre-reconstruction filtering of images from single photon emission computerized tomography.


Subject(s)
Computers , Radionuclide Imaging/methods , Models, Structural
9.
Surg Gynecol Obstet ; 141(2): 212-8, 1975 Aug.
Article in English | MEDLINE | ID: mdl-1154230

ABSTRACT

The immunologic status of 24 male patients admitted for acute alcoholic detoxification was evaluated by in vivo and in vitro parameters. In vivo reactivity, as measured by skin testing with a denovo antigen, dinitrochlorobenzene, as well as a recall antigen, tuberculin, was inact. However, both qualitative and quantitative defects were seen in vitro in the thymus-derived lymphocyte population. These defects were not seen in recovered alcoholics, that is, they appear reversible. The defects seen in the cell-mediated immunity of alcoholics may, in part, be responsible for the high incidence of head and neck cancer observed in this patient population.


Subject(s)
Alcoholism/immunology , Ethanol/pharmacology , Immunity , Adult , Bone Marrow/drug effects , Carcinoembryonic Antigen/analysis , Concanavalin A , Dinitrochlorobenzene/immunology , Humans , Immunity/drug effects , Immunoglobulin A/analysis , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Intradermal Tests , Lectins/metabolism , Liver Function Tests , Lymphocytes/analysis , Lymphocytes/drug effects , Lymphocytes/metabolism , Male , Middle Aged , Mitogens/metabolism , Skin Tests , Thymus Gland/drug effects , Tuberculin Test
SELECTION OF CITATIONS
SEARCH DETAIL
...